5 Top Stock Gainers for Wednesday: AMC, Constellation Pharma, Skillz

AMC Entertainment, Constellation Pharmaceuticals, Skillz, FuboTV and Eastman Kodak are five top stock gainers for Wednesday.
Author:
Publish date:

Stocks finished higher Wednesday as Wall Street looked toward U.S. jobs data at the end of the week to provide a fresh catalyst for the market's direction.

Here are some of the big movers in the stock market on Wednesday:

1. AMC Entertainment | Increase 95%

AMC Entertainment  (AMC) - Get Report soared to a record as the meme-stock favorite said it would launch a initiative called "AMC Investor Connect. That's a portal that will enable its 3.2 million retail investors to "self-identify" as stockholders and receive what the company calls "special offers" and updates.

2. Constellation Pharmaceuticals | Increase 66%

Shares of Constellation Pharmaceuticals  (CNST) - Get Report skyrocketed after the company agreed to be acquired by the Munich biopharma MorphoSys  (MOR) - Get Report for $34 a share, or $1.7 billion, cash. 

Constellation develops molecule therapeutics to treat cancer as well as inflammatory and immunologic disorders. 

3. Skillz | Increase 27%

Skillz  (SKLZ) - Get Report rose after the mobile-gaming company said it had agreed to acquire the marketing platform Aarki for about $150 million in cash and stock. 

Skillz said the acquisition would broaden its footprint across the mobile gaming industry by combining its competitive platform with Aarki’s advanced advertising capabilities.

4. FuboTV | Increase 17%

FuboTV  (FUBO) - Get Report advanced after the sports streaming company, which posted record revenue last month, upgraded its app dashboard to feature live stats and chances to win a year's free subscription to its service, according to Fast Company. 

Fubo said it was part of a bigger plan to let people bet on games through their televisions.

5. Eastman Kodak | Increase 15%

Eastman Kodak  (KODK) - Get Report climbed after the imaging giant, which filed under the bankruptcy laws in January, responded to a New York State Attorney General's Office filing seeking investigative testimony and documents from Kodak. 

The company said the attorney general was "wrong on the facts" and described its approach as a "novel and highly problematic legal theory that seeks to impose liability in the absence of intent."